Benzinga | Nov 23, 2021 06:35AM EST

SVB Leerink Initiates Coverage On Aura Biosciences with Outperform Rating, Announces Price Target of $40

SVB Leerink analyst Andrew Berens initiates coverage on Aura Biosciences (NASDAQ:AURA) with a Outperform rating and announces Price Target of $40.